New shot could bring relief to eczema sufferers
NCT ID NCT07479615
First seen Mar 20, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study tests an investigational drug called MG-K10 in about 498 adults and teenagers (age 12+) with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with standard creams. Participants will receive either MG-K10 or a placebo injection to see if it reduces skin redness, itching, and rash. The goal is to find a new treatment option for people whose eczema is hard to control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.